Aerobiotix Awarded Premier, Inc. Group Purchasing Contract to Provide Air Disinfection Technology to Premier Member Hospitals

WEST CARROLLTON, Ohio--()--Aerobiotix, Inc. today announced it has been awarded a group purchasing agreement for its patented Illuvia® ultraviolet air disinfection products with Premier, Inc., a leading health care improvement company uniting an alliance of approximately 3,900 U.S. hospitals and 150,000 other provider organizations. This agreement, effective February 1, 2018, underscores the growing value of environmental disinfection technologies to Premier’s member hospitals, who translate cleaner environments into reduced risks for hospital acquired infection (HAI). Aerobiotix technologies have been proven in peer-reviewed studies to greatly reduce air microbial levels in multiple critical health care settings, including operating rooms.

“Contracting with Premier provides its members with efficient access to our technology, shortening the cycle between needs and interventions.”

As hospitals face increasing pressure to reduce their HAI rates, evidence continues to mount that hospital air quality plays a significant role in the incidence of infections, including surgical site infection. Hospitals using Aerobiotix ultraviolet air disinfection systems have shown reductions in air microbial levels greater than 50 percent.

“Killing pathogens in the environment before they gain access to patients has always been the ideal strategy to prevent hospital acquired infections. With Aerobiotix, technology is finally catching up with this ideal,” said David Kirschman, M.D., chief executive of Aerobiotix. “Contracting with Premier provides its members with efficient access to our technology, shortening the cycle between needs and interventions.”

Aerobiotix Illuvia® ultraviolet air disinfection systems work continuously in occupied spaces to reduce environmental pathogen levels, so there is minimal workflow impact. The deployable systems both disinfect and sense air to give real-time feedback of air quality indicators to hospital staff.

About Aerobiotix, Inc.

Aerobiotix is a privately-held company positioned as the global leader in air disinfection systems for health care settings. Aerobiotix utilizes a suite of patented technologies to remove pathogens that cause hospital acquired infections and support a safe environment of care. Aerobiotix partners with clinicians, administrators and technologists to create better environments for care globally.

About Premier, Inc.

Premier, Inc. (NASDAQ: PINC) is a health care improvement company uniting an alliance of approximately 3,900 U.S. hospitals and more than 150,000 other provider organizations. Our mission is simple: To improve the health of communities. As an industry leader, Premier has created one of the most comprehensive databases of actionable data, clinical best practices and efficiency improvement strategies.

For information, visit www.aerobiotix.com.

Contacts

Aerobiotix, Inc.
Nathan Utz
Director, Client Services
nu@aerobiotix.com

Recent Stories

RSS feed for Aerobiotix, Inc.

Release Summary

Aerobiotix Awarded Premier, Inc. Group Purchasing Contract to Provide Air Disinfection Technology to Premier Member Hospitals.

Aerobiotix, Inc.